Published · Aurelis Peptides
Acetate and trifluoroacetate are different counterions that may be present in synthetic peptide materials. A counterion is a companion ion associated with an oppositely charged molecule. When comparing peptide acetate vs TFA, keep the peptide identity, chemical form and amount as separate fields.
A familiar name and a milligram label are a useful starting point. A complete specification also says what material was measured and how the result is expressed. This guide explains those questions; it does not identify an acetate or TFA variant as available in the Aurelis catalogue.
What does the counterion field describe?
In peptide records, TFA commonly refers to trifluoroacetic acid or its trifluoroacetate counterion, depending on the context. A primary analytical study describes acetate and trifluoroacetate in synthetic peptide samples and measures the corresponding acids with a specific assay. Ask which meaning the document uses. Read the analytical study.
| Record field | Acetate description | TFA description |
|---|---|---|
| Named counterion | Acetate | Trifluoroacetate |
| Question for the issuer | What was measured and reported? | Does TFA identify the acid, counterion or reported assay? |
| Quantitative detail | Result, units and method | Result, units and method |
| Catalogue availability | Requires confirmation | Requires confirmation |
Why the amount needs its own explanation
Peptide material can include components besides the target peptide. In its synthetic-oxytocin comparison, BIPM evaluated peptide-related impurities, water, residual solvents and counterions separately. That analytical example explains why a material-composition question needs more than one result. It is not a test of an Aurelis product. Read the BIPM report, page 8.
Ask whether the stated milligrams refer to peptide content or to a defined salt or material basis. Do not apply an assumed correction percentage to a catalogue amount. A calculation needs the actual composition, relevant measurements and the reporting convention used by the issuer.
Apply the questions to a named catalogue entry
Aurelis lists BPC-157 10 mg, Semax 10 mg, Selank 10 mg. Each amount is listed content per unit. None of those listings, by itself, establishes an acetate or TFA specification.
For a BPC-157 enquiry, retain the full peptide name and request the offered chemical form. Do the same for Semax or Selank instead of transferring an answer from another peptide. Keep the selected amount attached to that identity. Our peptide naming example shows why matching names and molecular records matters.
Use a four-field document check
- Identity: full peptide name, sequence or other agreed molecular specification.
- Chemical form: stated salt or counterion details, with unanswered fields left visible.
- Amount: result, units and an explanation of the peptide-content or material basis.
- Traceability: the lot identifier, report date, method and document issuer for the offered item.
Review these fields together. If the quotation and report use different terms, ask for a written reconciliation before treating them as the same specification. The quality-documentation guide provides the wider review framework.
Keep the presentation separate
Both vials and pen-style kits belong in a format enquiry. A counterion description does not define a kit component list, liquid fill, concentration or delivered amount. Confirm those presentation details for the particular offered configuration.
The content vs concentration guide explains the distinction between mg and mg/mL. Keep any requested nasal presentation equally specific; a peptide name alone does not establish the finished formulation.
Ask for a clearly matched response
Send the peptide name, catalogue amount, preferred presentation and destination in Australia, Canada or the USA. Include a counterion requirement if your project has one, and ask whether it can be met. Request current availability and matching records rather than assuming either chemical form is stocked.
Send a specification enquiry or email sales@aurelispeptides.com. Keep the reply with the selected catalogue entry so later comparisons use the same agreed fields.